Form 4 PEDEVCO CORP For: Jun 22 Filed by: Clark Moore
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color: green;
background-color: white;
... (continue reading...)
Form 4 AIAI Holdings Corp For: Jun 18 Filed by: Carlton Charles Craig
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color: green;
background-color: white;
... (continue reading...)
Form 6-K Rubico Inc. For: Jun 23
UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of June 2026
Commission File Number: 001-42684
Rubico Inc.(Translation of registrant's name into English)
20 Iouliou Kaisara Str19002 PaianiaAthens, Greece(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports... (continue reading...)
Form 4 FIRST MERCHANTS CORP For: Jun 23 Filed by: HARDWICK MARK K
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color: green;
background-color: white;
... (continue reading...)
Form 4 Olema Pharmaceuticals, For: Jun 18 Filed by: Harmon Cyrus
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color: green;
background-color: white;
... (continue reading...)
More SEC Filings
View Older Stories-
Form 497 AIM ETF Products Trust
-
Form 6-K Rubico Inc. For: Jun 23
-
Form 424B2 BANK OF NOVA SCOTIA
-
Form 424B2 CITIGROUP INC
-
Form D CRED RN-D Cayman Unit
-
Form 424B2 GOLDMAN SACHS GROUP INC
-
Form 4 Olema Pharmaceuticals, For: Jun 18 Filed by: BUTITTA CYNTHIA M
-
Form 4 Guardant Health, Inc. For: Jun 22 Filed by: Tariq Musa
-
Form 11-K JANUS HENDERSON GROUP For: Dec 31
-
Form 4 Guardant Health, Inc. For: Jun 22 Filed by: POTTER MYRTLE S
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 4 Olema Pharmaceuticals, For: Jun 18 Filed by: Garland J. Scott
-
Form 8-K ENANTA PHARMACEUTICALS For: Jun 23
-
Form 425 Evernorth Holdings Inc. Filed by: Evernorth Holdings Inc.
-
Form 4 Guardant Health, Inc. For: May 21 Filed by: MIGNONE ROBERTO
-
Form 4 Olema Pharmaceuticals, For: Jun 18 Filed by: Hrustanovic Gorjan
-
Form FWP BofA Finance LLC Filed by: BofA Finance LLC
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 424B2 CITIGROUP INC
-
Form FWP BANK OF AMERICA CORP Filed by: BANK OF AMERICA CORP /DE/
-
Form 4 Olema Pharmaceuticals, For: Jun 18 Filed by: CLARK IAN T
-
Form 424B2 BofA Finance LLC
-
Form 424B3 CNL Strategic Capital,
-
Form D Kalea Ventures Funds
-
Form 424B2 HSBC USA INC /MD/
-
Form 4 Olema Pharmaceuticals, For: Jun 18 Filed by: Larson Yi
-
Form 6-K/A VivoPower PLC For: Jun 23
-
Form 11-K Liberty Energy Inc. For: Dec 31
-
Form D/A CAZ Private Equity Owner
-
Form 11-K Ingersoll Rand Inc. For: Dec 31
-
Form 424B2 GOLDMAN SACHS GROUP INC
-
Form 4 AGIOS PHARMACEUTICALS, For: Jun 18 Filed by: Ballal Rahul D.
-
Form 424B2 GOLDMAN SACHS GROUP INC
-
Form 425 Axalta Coating Systems Filed by: AKZO NOBEL NV
-
Form 4 Olema Pharmaceuticals, For: Jun 18 Filed by: Horning Sandra
-
Form 4 AGIOS PHARMACEUTICALS, For: Jun 18 Filed by: CAPELLO JEFFREY D
-
Form 424B2 GOLDMAN SACHS GROUP INC
-
Form 4 Indivior Pharmaceuticals For: Jun 22 Filed by: Ciaffoni Joseph
-
Form 4 AGIOS PHARMACEUTICALS, For: Jun 18 Filed by: Foster-Cheek Kaye I
-
Form APP ORDR J.P. Morgan Investment
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 8-K CNL Strategic Capital, For: Jun 23
-
Form 4 Olema Pharmaceuticals, For: Jun 18 Filed by: Raman Prakash
-
Form 424B2 BofA Finance LLC
-
Form 424B2 GOLDMAN SACHS GROUP INC
-
Form APP NTC J.P. Morgan Investment
-
Form DEF 14A 22nd Century Group, Inc. For: Jun 23
-
Form 4 AGIOS PHARMACEUTICALS, For: Jun 18 Filed by: FOUSE JACQUALYN A
-
Form 424B2 CITIGROUP INC
-
Form 424B2 JPMORGAN CHASE & CO
